Literature DB >> 32341475

Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations.

Sheyda Azimi1,2, Aled E L Roberts3, Shengyun Peng2, Joshua S Weitz1,2,4, Alan McNally5, Samuel P Brown1,2, Stephen P Diggle6,7.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that chronically infects the lungs of individuals with cystic fibrosis (CF) by forming antibiotic-resistant biofilms. Emergence of phenotypically diverse isolates within CF P. aeruginosa populations has previously been reported; however, the impact of heterogeneity on social behaviors and community function is poorly understood. Here we describe how this heterogeneity impacts on behavioral traits by evolving the strain PAO1 in biofilms grown in a synthetic sputum medium for 50 days. We measured social trait production and antibiotic tolerance, and used a metagenomic approach to analyze and assess genomic changes over the duration of the evolution experiment. We found that (i) evolutionary trajectories were reproducible in independently evolving populations; (ii) over 60% of genomic diversity occurred within the first 10 days of selection. We then focused on quorum sensing (QS), a well-studied P. aeruginosa trait that is commonly mutated in strains isolated from CF lungs. We found that at the population level, (i) evolution in sputum medium selected for decreased the production of QS and QS-dependent traits; (ii) there was a significant correlation between lasR mutant frequency, the loss of protease, and the 3O-C12-HSL signal, and an increase in resistance to clinically relevant β-lactam antibiotics, despite no previous antibiotic exposure. Overall, our findings provide insights into the effect of allelic polymorphism on community functions in diverse P. aeruginosa populations. Further, we demonstrate that P. aeruginosa population and evolutionary dynamics can impact on traits important for virulence and can lead to increased tolerance to β-lactam antibiotics.

Entities:  

Mesh:

Year:  2020        PMID: 32341475      PMCID: PMC7368067          DOI: 10.1038/s41396-020-0652-0

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  88 in total

Review 1.  Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.

Authors:  André M Cantin; Dominik Hartl; Michael W Konstan; James F Chmiel
Journal:  J Cyst Fibros       Date:  2015-03-23       Impact factor: 5.482

2.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

Authors:  J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

3.  Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.

Authors:  B Frederiksen; C Koch; N Høiby
Journal:  Pediatr Pulmonol       Date:  1997-05

Review 4.  Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.

Authors:  Gerd Döring; Iyer G Parameswaran; Timothy F Murphy
Journal:  FEMS Microbiol Rev       Date:  2011-01       Impact factor: 16.408

5.  Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis.

Authors:  Peter Jorth; Zarmina Ehsan; Amir Rezayat; Ellen Caldwell; Christopher Pope; John J Brewington; Christopher H Goss; Dan Benscoter; John P Clancy; Pradeep K Singh
Journal:  Cell Rep       Date:  2019-04-23       Impact factor: 9.423

Review 6.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

Authors:  Michael Hogardt; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2010-10-12       Impact factor: 3.473

Review 7.  Cystic fibrosis.

Authors:  J Stuart Elborn
Journal:  Lancet       Date:  2016-04-29       Impact factor: 79.321

8.  Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Mark J Fiandaca; Jette Pedersen; Christine Rønne Hansen; Claus Bøgelund Andersen; Tacjana Pressler; Michael Givskov; Niels Høiby
Journal:  Pediatr Pulmonol       Date:  2009-06

9.  The Dynamics of Disease Progression in Cystic Fibrosis.

Authors:  Frederick R Adler; Theodore G Liou
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

10.  Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat.

Authors:  Stephen P Diggle; Marvin Whiteley
Journal:  Microbiology       Date:  2020-01       Impact factor: 2.777

View more
  11 in total

1.  Genomics of Diversification of Pseudomonas aeruginosa in Cystic Fibrosis Lung-like Conditions.

Authors:  Alana Schick; Sonal Shewaramani; Rees Kassen
Journal:  Genome Biol Evol       Date:  2022-05-31       Impact factor: 4.065

2.  The Nutritional Environment Is Sufficient To Select Coexisting Biofilm and Quorum Sensing Mutants of Pseudomonas aeruginosa.

Authors:  Michelle R Scribner; Amelia C Stephens; Justin L Huong; Anthony R Richardson; Vaughn S Cooper
Journal:  J Bacteriol       Date:  2022-01-03       Impact factor: 3.476

Review 3.  Biofilm antimicrobial susceptibility through an experimental evolutionary lens.

Authors:  Tom Coenye; Mona Bové; Thomas Bjarnsholt
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-18       Impact factor: 8.462

4.  Pleiotropic constraints promote the evolution of cooperation in cellular groups.

Authors:  Michael A Bentley; Christian A Yates; Jotun Hein; Gail M Preston; Kevin R Foster
Journal:  PLoS Biol       Date:  2022-06-03       Impact factor: 9.593

5.  The evolution of virulence in Pseudomonas aeruginosa during chronic wound infection.

Authors:  Jelly Vanderwoude; Derek Fleming; Sheyda Azimi; Urvish Trivedi; Kendra P Rumbaugh; Stephen P Diggle
Journal:  Proc Biol Sci       Date:  2020-10-21       Impact factor: 5.349

6.  Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.

Authors:  Madeline Mei; Jacob Thomas; Stephen P Diggle
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

Review 7.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

8.  Kin selection for cooperation in natural bacterial populations.

Authors:  Laurence J Belcher; Anna E Dewar; Melanie Ghoul; Stuart A West
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

9.  Intraspecies Signaling between Common Variants of Pseudomonas aeruginosa Increases Production of Quorum-Sensing-Controlled Virulence Factors.

Authors:  Dallas L Mould; Nico J Botelho; Deborah A Hogan
Journal:  mBio       Date:  2020-08-25       Impact factor: 7.867

10.  O-Specific Antigen-Dependent Surface Hydrophobicity Mediates Aggregate Assembly Type in Pseudomonas aeruginosa.

Authors:  Sheyda Azimi; Jacob Thomas; Sara E Cleland; Jennifer E Curtis; Joanna B Goldberg; Stephen P Diggle
Journal:  mBio       Date:  2021-08-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.